PresentationChristopher David O'ReillyGlobal Head of Investor Relations & Global Finance Hello, everyone, and welcome to this investor call to discuss oveporexton Phase III data and commercial readiness. My name is Christopher O'Reilly, Head of Investor Relations at Takeda. Today's presentation will take place in English with simultaneous Japanese translation. During the Q&A, we may take questions in either English or Japanese. [Operator Instructions] I'd like to remind everyone that in this call, we will b ...